Please select a publication to download. All documents are in PDF format.

September 2021

Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs

June 2020

Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells

February 2017

Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo

November 2016

T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

June 2016

Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma
in a patient

January 2014

Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I

February 2013

Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients

June 2008

Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

August 2005

IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response1